HOME >> MEDICINE >> NEWS
Landmark study results published in NEJM highlight breakthrough treatment for heart failure

MINNEAPOLIS, June 12, 2002 - Hundreds of thousands of Europeans who live with restricted energy, mobility and independence due to heart failure could benefit significantly from a breakthrough treatment featured in tomorrow's New England Journal of Medicine1. The published study results demonstrate the benefit of cardiac resynchronisation (CR) therapy with the InSync system from Medtronic, Inc. (NYSE: MDT) to help many people live well with moderate-to-severe heart failure. Over 3 million people in the G5 European markets alone (UK, Germany, Italy, France & Spain) suffer from heart failure2, a progressive and debilitating condition that is responsible for more hospitalisations than all forms of cancer combined.

Data from the Multicenter InSync Randomised Clinical Evaluation, known as MIRACLE, show that cardiac resynchronisation therapy systems helped many patients improve by at least one functional class, resulted in a greater improvement in patient quality of life than for those receiving drug therapy alone and reduced the risk of hospitalisation from worsening heart failure.

Approximately 450,0003 people in the G5 European countries are candidates for cardiac resynchronisation therapy; these patients have moderate-to-severe heart failure and also suffer from ventricular dysynchrony, which occurs when there is a time delay between the beating of the heart's two lower chambers, or ventricles. Cardiac resynchronisation therapy delivers electrical impulses to both sides of the heart to co-ordinate the contractions of the heart's ventricles and improve its efficiency to increase blood flow to the body.

The MIRACLE study was designed to measure therapeutic benefits of the InSync system, as determined by changes in New York Heart Association (NYHA) functional classification, distance walked in six minutes and improvements in quality of life. Findings are based on data from 453 patients with moderate-to-severe heart failure.

Conducted a
'"/>

Contact: Amanda Boswell
amanda.boswell@ketchum.com
44-207-611-3571
Ketchum
12-Jun-2002


Page: 1 2 3 4

Related medicine news :

1. Landmark survey reveals asthma in children remains significantly out of control in the United States
2. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
3. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
4. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
5. Landmark study demonstrates potential for nerve regeneration treatment of stroke
6. Landmark study uncovers reasons behind recurring back injury
7. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... Colo. (PRWEB) , ... August 14, 2019 , ... Inc. ... #2008 on its annual Inc. 5000 list, the most prestigious ranking of the nation’s ... #41 among Colorado based companies and #153 in the Health sector. The list represents ...
(Date:8/14/2019)... PASADENA, Calif. (PRWEB) , ... August 13, 2019 ... ... Pasadena, California has joined the esteemed Haute Beauty network. , The Haute Beauty ... privileged to present Dr. Reyes-Bergano as a leading aesthetic medicine expert and our ...
(Date:8/14/2019)... ... August 14, 2019 , ... Today, consumers are taking a harder look ... their physical body, emotions and energy levels. The trick is finding food and beverages ... , That’s why founder Chris Harper created Chase – a delicious, guilt ...
(Date:8/12/2019)... ... August 12, 2019 , ... ... the $56,595,000 Series 2019A&B Bonds for Lesley University, which is currently rated A-/Stable ... 2019 Bonds will be used primarily to refund the outstanding debt on the ...
(Date:8/9/2019)... , ... August 09, 2019 , ... ... the continuation of its global expansion into Europe’s third largest pharmaceutical market with ... , Advanced Clinical’s entrance into Italy now completes the organization’s thorough coverage of ...
Breaking Medicine News(10 mins):
(Date:8/16/2019)... ... August 16, 2019 , ... ... GA, 30501, is a comprehensive family dental practice that serves the Gainesville community ... cosmetic dentistry , endodontics and restorative dental care. The well-established practice is ...
(Date:8/16/2019)... ... August 16, 2019 , ... ... 2005, announced it has successfully completed enrollment of 690 patients for a phase ... dose ranging, multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of ...
(Date:8/15/2019)... ... August 15, 2019 , ... Donor ... for intended parents who are looking for egg donors, gestational surrogates and sperm ... looking for the ultimate concierge service and hands-on help in creating their families ...
Breaking Medicine Technology:
Cached News: